Alice Carrier - Publications

Adaptation of redox metabolism in drug-tolerant persister cells is a vulnerability to prevent relapse in pancreatic cancer.

Journal: Oncogenesis

Published: March 06, 2025

Integrative study of skeletal muscle mitochondrial dysfunction in a murine pancreatic cancer-induced cachexia model.

Journal: eLife

Published: October 18, 2024

A pharmacological strategy to recapitulate exercise-induced antitumoral immunity.

Journal: Trends in pharmacological sciences

Published: July 22, 2022

Pesticides and pancreatic adenocarcinoma: A transversal epidemiological, environmental and mechanistic narrative review.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: April 26, 2022

A novel anticancer pharmacological agent targeting mitochondrial complex I.

Journal: Trends in pharmacological sciences

Published: February 09, 2022

Autophagy Contributes to Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Tumors.

Journal: Cells

Published: December 21, 2021

Meeting report of the 4th biennial Metabolism and Cancer symposium.

Journal: The FEBS journal

Published: October 05, 2021

Combining the antianginal drug perhexiline with chemotherapy induces complete pancreatic cancer regression in vivo.

Journal: iScience

Published: September 11, 2021

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.

Journal: Autophagy

Published: February 26, 2021

Targeting Redox Metabolism in Pancreatic Cancer.

Journal: International journal of molecular sciences

Published: December 31, 2020

Pancreatic cancer intrinsic PI3Kα activity accelerates metastasis and rewires macrophage component.

Journal: EMBO molecular medicine

Published: September 23, 2020

TP53INP1 exerts neuroprotection under ageing and Parkinson's disease-related stress condition.

Journal: Cell death & disease

Published: September 22, 2020